Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
Joseph L. Simonson, Christine Tanaka Esposito, T. Frantzen, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 3, pp. e176-e183
Open Access | Times Cited: 11

Showing 11 citing articles:

Role of inhaled antibiotics in the era of highly effective CFTR modulators
J.S. Elborn, Francesco Blasi, Pierre‐Régis Burgel, et al.
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220154-220154
Open Access | Times Cited: 29
The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators
Erica A. Roesch, Abdelkader Rahmaoui, Robert A. Lazarus, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 9, pp. 677-691
Open Access | Times Cited: 2
Patient-Reported Outcomes and Healthcare Practices: A Retrospective Analysis of Cystic Fibrosis Management During the COVID-19 Pandemic
Seyed Ahmad Tabatabaii, Abdolhamid Taghizadeh-Behbahani, Ghamartaj Khanbabaee, et al.
Archives of Pediatric Infectious Diseases (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Cystic fibrosis year in review 2022
Jeeyeon Kim, Benjamin C. Lyman, Adrienne P. Savant
Pediatric Pulmonology (2023) Vol. 58, Iss. 11, pp. 3013-3022
Open Access | Times Cited: 4
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
The Fear of COVID-19: Effects on Psychosocial Factors and Quality of Life in Patients with Cystic Fibrosis
Elif Kabasakal, Pınar Kaya Ciddi
Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi (2024) Vol. 11, Iss. 1, pp. 21-37
Open Access
Mental Health of Cystic Fibrosis Patients and the COVID-19 Pandemic in Poland: A Single-Center Comparative Study
Magdalena Humaj-Grysztar, Marta Rachel, Olga Śmiech-Michalec, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 16056-16056
Open Access | Times Cited: 3
A percepção do impacto da Covid-19 na vida de crianças e adolescentes com fibrose cística
Danielle Portella Ferreira, Saint Clair Gomes, Mariana Cardim Novaes, et al.
Interface - Comunicação Saúde Educação (2023) Vol. 27
Open Access
El papel de los antibióticos inhalados en la era de los moduladores de CFTR de alta eficacia
J.S. Elborn, Francesco Blasi, Pierre‐Régis Burgel, et al.
Kompass Neumología (2023) Vol. 5, Iss. 3, pp. 96-102
Open Access
Page 1

Scroll to top